title: RAN-seq of MCF10DCIS tumor from NOD/SCID mouse: relacorilant treated
design: One million MCF10DCIS cells were injected bilaterally into the mammary fat pad of 6-8 week old female NOD/SCID mice. All mice were injected with 80% DCIS parental + 20% DCIS4 mixed cells. Relacorilant, 30 mg/kg, or vehicle control treatment started one week after cells were injected. Drug was administered via oral gavage every Monday, Wednesday and Friday.